STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Revenue
5,935.90 5,459.50 5,138.70 4,536.27 4,223.40 3,107.52 3,030.90 2,782.17 2,620.00 2,612.76
Revenue Growth
8.73% 6.24% 13.28% 7.41% 35.91% 2.53% 8.94% 6.19% 0.28% 16.71%
Cost of Revenue
3,309.40 3,056.80 2,920.60 2,555.54 2,340.40 1,764.42 1,710.90 1,607.18 1,527.25 1,586.54
Gross Profit
2,626.50 2,402.70 2,218.10 1,980.73 1,883.01 1,343.10 1,320.00 1,174.99 1,092.75 1,026.21
R&D Expenses
112.90 107.60 103.70 98.48 86.66 66.33 65.55 63.04 60.78 59.40
SG&A Expenses
1,407.70 1,334.30 1,252.30 1,090.66 1,318.48 731.32 716.73 669.94 631.98 682.04
Operating Income
1,101.80 866.60 836.10 791.10 477.81 548.37 537.05 411.02 399.88 226.21
Non-operating Income/Expense
(54.40) (70.50) (133.40) (110.83) (111.01) (30.83) (38.29) (41.99) (44.90) (41.56)
Non-operating Interest Expenses
60.70 86.30 144.40 107.96 89.49 37.18 40.28 45.02 50.63 44.52
EBT
1,047.30 796.20 702.80 680.27 366.80 517.53 498.75 369.03 354.98 184.65
Income Tax Provision
262.20 184.70 149.50 124.07 82.34 120.66 90.90 64.28 63.36 74.02
Income after Tax
785.10 611.50 553.30 556.20 284.46 396.87 407.86 304.75 291.62 110.63
Dividends (Preferred)
— 0.10 0.10 0.00 — — 0.00 — — —
Non-Controlling Interest
2.80 1.40 1.80 (1.22) (1.02) (0.53) 0.20 1.03 0.71 0.67
Net Income Common
782.30 614.60 378.20 107.03 243.89 397.40 407.66 303.72 290.92 109.97
EPS (Basic)
7.97 6.24 3.83 1.07 2.50 4.66 4.81 3.59 3.42 1.29
EPS (Diluted)
7.93 6.20 3.81 1.07 2.48 4.63 4.76 3.56 3.39 1.28
Shares (Basic, Weighted)
98.20 98.60 98.80 99.71 97.54 85.20 84.78 84.58 85.03 85.47
Shares (Diluted, Weighted)
98.70 99.10 99.40 100.25 98.33 85.90 85.64 85.47 85.71 86.09
Gross Margin
44.25% 44.01% 43.16% 43.66% 44.59% 43.22% 43.55% 42.23% 41.71% 39.28%
EBIT Margin
18.56% 15.87% 16.27% 17.44% 11.31% 17.65% 17.72% 14.77% 15.26% 8.66%
EBT margin
17.64% 14.58% 13.68% 15.00% 8.69% 16.65% 16.46% 13.26% 13.55% 7.07%
Net Profit Margin
13.18% 11.26% 7.36% 2.36% 5.77% 12.79% 13.45% 10.92% 11.10% 4.21%
Free Cash Flow Margin
16.56% 14.42% 12.07% 9.03% 9.45% 14.51% 12.54% 12.77% 11.23% 9.80%
EBITDA
1,588.30 1,342.80 1,406.10 1,351.36 1,097.58 767.61 734.28 636.94 578.22 472.70
EBIT
1,101.80 866.60 836.10 791.10 477.81 548.37 537.05 411.02 399.88 226.21
Income from Continuous Operations
785.10 611.60 553.30 556.20 284.46 396.87 407.86 304.75 291.62 110.63
Income from Discontinued Operations
— 4.50 (173.20) (450.38) (41.59) — — — — —
Consolidated Net Income/Loss
785.10 616.10 380.10 105.81 242.87 396.87 407.86 304.75 291.62 110.63
EPS (Basic, from Continuous Ops)
7.97 6.19 5.58 5.59 2.93 4.66 4.81 3.60 3.43 1.29
EPS (Basic, from Discontinued Ops)
— 0.05 (1.75) (4.52) (0.43) — — — — —
EPS (Basic, Consolidated)
7.99 6.25 3.85 1.06 2.49 4.66 4.81 3.60 3.43 1.29
EPS (Diluted, from Cont. Ops)
7.93 6.16 5.55 5.56 2.90 4.62 4.76 3.57 3.40 1.29
EPS (Diluted, from Disc. Ops)
— 0.00 0.00 0.00 0.00 — — — — —
Shares (Diluted, Average)
98.70 99.07 99.36 100.25 98.33 85.90 85.64 85.47 85.71 86.09
EPS (Diluted, Consolidated)
7.95 6.22 3.82 1.06 2.47 4.62 4.76 3.57 3.40 1.29
EBITDA Margin
26.76% 24.60% 27.36% 29.79% 25.99% 24.70% 24.23% 22.89% 22.07% 18.09%
Operating Cash Flow Margin
22.60% 21.03% 18.94% 16.69% 16.21% 22.19% 19.48% 19.39% 17.47% 16.23%

Fold the line items

In millions of $ except per-share values · columns are period end dates